British Journal of Anaesthesia, Vol 79, Issue 3 301-305, Copyright © 1997 by The Board of Management and Trustees of the British Journal of Anaesthesia
A. Hiller and P. H. Rosenberg
Several studies have reported transient neurological symptoms after spinal
anaesthesia with 5% lignocaine. In order to evaluate the role of
concentrated solutions of local anaesthetic in the development of transient
neurological symptoms, 200 ASA I or II patients undergoing minor
orthopaedic or rectal surgery under spinal anaesthesia were allocated
randomly to receive 4% mepivacaine 80 mg or hyperbaric 0.5% bupivacaine 10
mg. All patients were interviewed by an anaesthetist approximately 24 h
after spinal anaesthesia, and after 1 week patients were asked to return a
written questionnaire. The incidence of transient neurological symptoms
consisting of pain in the buttocks or pain radiating symmetrically to the
lower extremities differed (P < 0.001) between patients receiving
mepivacaine (30%) and those receiving bupivacaine (3%). Hyperbaric 0.5%
bupivacaine can be recommended for minor operations on the lower abdomen or
lower extremities.
CLINICAL INVESTIGATIONS
Transient neurological symptoms after spinal anaesthesia with 4% mepivacaine and 0.5% bupivacaine
Department of Anaesthesia, Kuusankoski District Hospital, FIN-45750 Sairaalamaki, Finland; Department of Anaesthesiology, Helsinki University Central Hospital, FIN-00290 Helsinki, Finland
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. T. YaDeau, G. A. Liguori, and V. M. Zayas The Incidence of Transient Neurologic Symptoms After Spinal Anesthesia with Mepivacaine Anesth. Analg., September 1, 2005; 101(3): 661 - 665. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zaric, C. Christiansen, N. L. Pace, and Y. Punjasawadwong Transient Neurologic Symptoms After Spinal Anesthesia with Lidocaine Versus Other Local Anesthetics: A Systematic Review of Randomized, Controlled Trials Anesth. Analg., June 1, 2005; 100(6): 1811 - 1816. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Drasner Chloroprocaine Spinal Anesthesia: Back to the Future? Anesth. Analg., February 1, 2005; 100(2): 549 - 552. [Full Text] [PDF] |
||||
![]() |
J. V. Valanne, A.-M. Korhonen, R. M. Jokela, P. Ravaska, and K. K. Korttila Selective Spinal Anesthesia: A Comparison of Hyperbaric Bupivacaine 4 mg Versus 6 mg for Outpatient Knee Arthroscopy Anesth. Analg., December 1, 2001; 93(6): 1377 - 9. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Schneider and D. J. Birnbach Lidocaine Neurotoxicity in the Obstetric Patient: Is the Water Safe? Anesth. Analg., February 1, 2001; 92(2): 287 - 290. [Full Text] [PDF] |
||||
![]() |
J. Philip, S. K. Sharma, V. N. R. Gottumukkala, B. J. Perez, E. A. Slaymaker, and J. Wiley Transient Neurologic Symptoms After Spinal Anesthesia with Lidocaine in Obstetric Patients Anesth. Analg., February 1, 2001; 92(2): 405 - 409. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Zayas, G. A. Liguori, M. F. Chisholm, M. H. Susman, and M. A. Gordon Dose Response Relationships for Isobaric Spinal Mepivacaine Using the Combined Spinal Epidural Technique Anesth. Analg., November 1, 1999; 89(5): 1167 - 1167. [Abstract] [Full Text] [PDF] |
||||
